← Eichor
Study identifier: NCT02290795 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vitreopapillary Interface and Optic Disc Morphology

Condition: Posterior Vitreous Detachment · Vitreomacular Traction · Glaucoma  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The vitreous fills the posterior chamber of the eye and is firmly attached, at the posterior pole, to the macula and the optic nerve head (ONH). With formation of a stepwise posterior vitreous detachment (PVD) exerted tractional forces could influence retinal functioning. Especially in patients with glaucoma the influence of vitreous traction to the ONH could mask progression, interfere with current imaging techniques and even be a cause of ONH hemorrhages. Therefore the aim of this study is to investigate whether vitreopapillary traction has a significant effect on diagnosis and follow up of glaucoma patients.

This description comes directly from the study's public registry record.

Talk to the study team

Ingeborg Stalmans, MD, PhD  ·  016 33 23 70  ·  ingeborg.stalmans@uzleuven.be

Koen Willekens, MD  ·  016 33 23 70  ·  koen.willekens@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospitals LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02290795